Company: ARTL
Filing Date: 2025-08-07
Form Type: DEF 14A
Source: 0001640334-25-001376
Chunk: 22

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-08-07
Form: DEF 14A
Chunk 22
---
 it is the intention of the individuals we have designated as proxies to vote the shares that they represent on such matters in accordance with their judgment.

We are subject to the informational requirements of the Exchange Act and, therefore, we file annual, quarterly, and current reports, proxy statements, and other information with the SEC. Our SEC filings are available to the public on the SEC’s website at www.sec.gov or on our website at www.artelobio.com under “Investor – SEC Filings.” You may also obtain a copy of any of our SEC filings by sending a written request to Artelo Biosciences, Inc., Attn: Investor Relations, 505 Lomas Santa Fe, Suite 160, Solana Beach, CA 92075.

| Dated: August 7, 2025 | By order of the Board of Directors, 
 By:                                 | /s/ Gregory D. Gorgas                 |
|:----------------------|:------------------------------------|:--------------------------------------|
|                       |                                     | Gregory D. Gorgas                     |
|                       |                                     | President and Chief Executive Officer |

| 15 |

ANNEX A

<div align='center'>AMENDMENT OF ARTICLES OF INCORPORATION TO INCREASE THE AUTHORIZED SHARES OF COMMON STOCK</div>

ANNEX B

<div align='center'>AMENDMENT OF ARTICLES OF INCORPORATION TO INCREASE THE AUTHORIZED SHARES OF PREFERRED STOCK</div>

<div align='center'>ATTACHMENT

TO

CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION

OF

ARTELO BIOSCIENCES, INC.

ENTITY NUMBER E0258042011-1</div>

The Articles of Incorporation of Artelo Biosciences, Inc. a Nevada corporation (the “Corporation”), as filed with the Nevada Secretary of State on May 2, 2011, and as amended from time to time, shall be and hereby is amended as follows:

RESOLVED, that Article 3 of the Corporation’s Articles of Incorporation, as amended, be and hereby is amended and restated in its entirely as follows:

“3 Authorized Stock. [500,000,000] shares of common stock with a par value of $0.001 per share and 10,000,000 shares of preferred stock, with a par value of $0.001 per share.

3.1 Preferred Stock. The shares of the Corporation’s Preferred Stock may be issued from time to time in one or